Endometrial cancer: open trials in Israel

10 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT07166094
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Trial Treatment · Phase 3 · Genmab
Assuta Ashdod Hospital, Ashdod · Rambam Medical Center, Haifa · CARMEL, Haifa · Wolfson Medical Center, Holon · Shaare Zedek Medical Center, Jerusalem · Galilee Medical Center, Nahariya
Registry updated 2026-11-03
NCT07286331
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Trial Treatment · Phase 3 · GlaxoSmithKline
Haifa · Kfar Saba
Registry updated 2026-11-03
NCT07022483
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Trial Treatment · Phase 3 · Daiichi Sankyo
Wolfson Medical Center, Holon
Registry updated 2026-10-27
NCT06340568
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Trial Treatment · Phase 3 · BioNTech SE
Hillel Yaffe Medical Center, Hadera · Lady Davis Carmel Medical Center, Haifa · Shaare Zedek, Jerusalem · Shaare Zedek Medical Center, Jerusalem · Hadassah Ein-Kerem Medical Center, Jerusalem · Rabin Medical Center-Beilinson Campus, Petah Tikva · Sheba medical center, Ramat Gan · Sourasky Medical Centre, Tel Aviv
Registry updated 2026-10-16
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Rambam Health Care Campus (Site 2025), Haifa · Carmel Hospital (Site 2023), Haifa · Shaare Zedek Medical Center (Site 2020), Jerusalem · Meir Medical Center. (Site 2021), Kfar Saba · Sourasky Medical Center (Site 2022), Tel Aviv
Registry updated 2026-10-13
NCT05797168
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
Haifa · Ramat Gan
Registry updated 2026-10-05
NCT03564340
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Rambam Health Care Campus, Haifa · Sharet Institute of Oncology, Jerusalem · Sheba medical center, Tel HaShomer
Registry updated 2026-09-25
NCT07044336
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Trial Treatment · Phase 3 · AstraZeneca
Ashdod · Hadera · Haifa · Holon · Jerusalem · Nahariya · Ramat Gan · Safed · Tel Aviv
Registry updated 2026-07-29
NCT06689956
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Research · Mayo Clinic
Meir Medical Center, Faculty of Medicine - Tel-Aviv University, Kefar Sava
Registry updated 2026-02-19
NCT05797831
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Trial Treatment · Phase 2/3 · Kartos Therapeutics, Inc.
Rambam Medical Center, Haifa · Shaare Zedek Medical Center, Jerusalem · Sourasky Medical Center, Tel Aviv
Registry updated 2024-05-02

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error